Dimitrios Athanasiou

European Medicines Agency PCWP Member; World Duchenne Organization Board Member; European Patient Forum Ethics Board Chair; Greek Patients Association Board Member; Rare Diseases Greece Vice Chair

Dimitrios Athanasiou holds a BA in Business Administration and an MBA in Financial Management. He speaks three European languages and has more than 25 years of experience with international business projects, working in various countries in consulting, developing, and reorganizing companies. When his son was diagnosed with Duchenne Muscular Dystrophy, a fatal and incurable rare disease, he became a strong international patient advocate in Duchenne and Rare Diseases. He was a board member of the European Patient Forum EPF, the umbrella of the patient organizations in Europe. He is a founding member and serves on the Board of the Greek Patients Association and is currently the Vice Chair of Rare Diseases Greece. In 2014 he was nominated patient expert by EMA for DMD and has participated in several of EMA’s Scientific Advice, SAG, Protocol Assistance, and CHMP pilot meetings for Duchenne, providing the essential patient representative perspective when companies request regulatory advice or approval. He was a PDCO member in the European Medicines Agency till 2023 and is currently a PCWP member.